Penserra Capital Management’s Genmab GMAB Stock Holding History

Penserra Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,105	Closed	-$48K	–	1432
2021 Q3	$48K	Buy	1,105 +15	+1%	+$673	﹤0.01%	1060
2021 Q2	$44K	Buy	1,090 +10	+0.9%	+$386	﹤0.01%	1033
2021 Q1	$35K	Buy	1,080 +5	+0.5%	+$188	﹤0.01%	875
2020 Q4	$43K	Buy	1,075 +707	+192%	+$26.4K	﹤0.01%	708
2020 Q3	$13K	Sell	368 -125,381	-100%	-$4.53M	﹤0.01%	793
2020 Q2	$4.26M	Buy	125,749 +123,779	+6,283%	+$3.37M	0.22%	125
2020 Q1	$54K	Buy	+1,970	New	+$43.9K	﹤0.01%	663

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Penserra Capital Management's GMAB Position: Q4 2021 in Review

Penserra Capital Management sold out of Genmab (GMAB) in Q4 2021, closing a stake of 1,105 shares — an estimated $48K sold.

Penserra Capital Management first reported a position in GMAB in Q1 2020 and held it in 7 quarters. The position peaked at $4.26M in Q2 2020. 211 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

Penserra Capital Management reported no remaining Genmab position as of Q4 2021 after selling out during the quarter.
Penserra Capital Management sold 1,105 Genmab shares in Q4 2021, an estimated $48K.
Penserra Capital Management first reported a position in Genmab in Q1 2020 and held it in 7 quarters.
Penserra Capital Management's Genmab position peaked at $4.26M in Q2 2020.
211 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.